Transcript The Ibogaine Community Worldwide – User to User

Ibogaine Community
Worldwide
User-to-User
BrugerForeningen
International Drug Users Day
(IDUD) 2008
Copenhagen, Denmark
31 October - 3 November 2008
Howard S. Lotsof
Dora Weiner Foundation
Staten Island, NY
Ibogaine Found in the West
African plant Tabernanthe
iboga
Iboga alkaloids are concentrated
in the bark of the root
Usable forms include scraped
or ground root bark
Total Alkaloid extract
Purified Chemical
Regulatory and Scientific
Development
The first attempt at drug development of ibogaine was
by the Dora Weiner Foundation in 1983.
In 1986, a for-profit corporation, NDA International,
Inc. was established and subsequently raised 4 million
towards the approval of ibogaine, initiating research
and patent development.
1991, National Institute on Drug Abuse ibogaine
research project.
1993, FDA approval for University of Miami clinical
study.
Ibogaine Patents
1. Rapid method for interrupting the narcotic
addiction syndrome, US 4,499,096 (1985)
2. Rapid method for interrupting the cocaine and
amphetamine abuse syndrome US 4,587,243
(1986)
3. Rapid method for attenuating the alcohol
dependency syndrome, US 4,957,523 (1989)
4. Rapid method for interrupting or attenuating the
nicotine/tobacco dependency syndrome, US
5,026,697 (1991)
5. Rapid method for interrupting or attenuating polydrug dependency syndromes, US 5, 124,994
(1992)
First scientific publication of
ibogaine antiaddictive effects
Ibogaine effects on
Morphine self-administration
(Glick et al. 1991)
Ibogaine effects on
Morphine withdrawal
(Glick et al. 1992)
Ibogaine effects on cocaine
(Cappendijk & Dzoljic. 1993)
Ibogaine effects on alcohol
(Rezvani et al. 1995)
Treatment Expectations
1. Interviews
For benefit of subject and provider
2. Safety testing
EKG, blood tests, echo stress test,
psych evaluations
3. Aftercare
Depending on desired outcome
Ibogaine:
Stages of effect
1. Visualization or waking
dream-like experience
3 - 6 hours
2. Cognitive evaluation
8 - 20 hours
3. Residual stimulation
12 - 72 hours
Ibogaine:
Side-effects
1. Nausea or vomiting
2. Ataxia
Ibogaine Advantages
1. Ibogaine significantly reduces withdrawal
2. Interrupts drug craving
3. Interrupts drug self-administration
4. Returning patients to a preaddictive state
5. Antibacterial
6. Returns free choice
7. Eliminates stigma
Ibogaine
1) User discovered
2) User developed
3) User supported
Ibogaine Activist
Advocacy Organizations Play
Role in Ibogaine Development
•
International Coalition for Addict Self-Help
(ICASH) 1989
•
Dutch Addict Self-Help (DASH) 1990
•
International Addict Self-Help (INTASH) 1992
•
Cures-Not Wars (ibogaine and other issues) 1994
•
Ibogaine Underground 2004
ICASH logo
Used to attract attention of government
officials and media
Nico Adriaans was one of the founders of both
the Rotterdam Junkies Union and Dutch Addict
Self-Help (DASH). DASH was an ibogaine selfhelp organization that petitioned the Dutch
government and organized drug users to demand
ibogaine availability. DASH provided ibogaine at
no cost to heroin users.
ICASH Organizing in the US
Cures-Not-Wars placed pressure
on NIDA to support Ibogaine
research through protests
Mindvox internet ibogaine list
(user advocacy continues)
“We all got to help each other best we can. No
one else gives a shit ‘bout us hippy freak
junkies? ”
anon.
To join send an email to
[email protected]
Ibogaine underground appears 2004
“FM- … We feel that continuing the focus
offshore, outside the US, has not served a
majority of people inside the US. Like many
other grassroots movements, which facilitated
change, treatments, sessions, need to be done
where they belong, in all major US cities, as
cost effectively as possible. “
http://www.drugwar.com/ibonyc.shtm
Ibogaine:
Question #1
asked by users
Will it get rid of withdrawal?
Opioid withdrawal in
human subjects
Early study shows significant efficacy in 25 out of 33 cases.
- Resolution of opioid withdrawal without signs of drug seeking behavior -
Ibogaine & Withdrawal
- Early findings ca. 1995 -
http://ibogaine.org/ibonarco.htm
Technology Transfer
1. While ibogaine effects may be generalized,
they are also specific to each individual.
2. Each person treated and each experience has
unique characteristics that must be observed
and responded to uniquely.
3. The administration of ibogaine requires, art,
craft and practice as do all human endeavor.
Ibogaine Prohibition
“a growing problem”
1. United States 1967
2. Belgium 1987
3. Switzerland 1989
4. Sweden 1999
5. Denmark 2003
6. France 2007
Why ibogaine should be available
1. Ibogaine significantly reduces opioid
withdrawal to heroin, methadone and
other narcotics
2. Interrupts drug craving
3. Returns users to a preaddictive state
4. Eliminates stigma
5. Offers freedom of choice
Why does US harm reduction (HRC)
support ibogaine and international
harm reduction (IHRA) not ?
HRC
1. Initially skeptical
2. Observed ibogaine proponents in their system
3. Now supports and refers to treatment
IHRA
1. Skeptical
2. No observation of treated persons
3. Education and treatment observations
required
The police apparatus and the
medical apparatus can be
equally oppressive. Users have a
right to make drug choices.
Ibogaine advocates are seeking a new
generation of activists to allow technology
transfer, training and treatment.
It is your right to use drugs and your right to
stop.
We would like to share the technology that
allows you to stop or limit use on your terms.
It’s in your hands now!
Patient rights - User rights
Freedom - Not oppression